Rajiv Malik

President at Viatris, Inc.

Rajiv Malik

Rajiv Malik

President at Viatris, Inc.

Overview
Career Highlights

Viatris, Inc.
Mylan Pharmaceuticals, Inc.
Mylan (Pty.) Ltd.

RelSci Relationships

811

Number of Boards

7

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals Rajiv Malik likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Chairman at Viatris, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Viatris, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Viatris, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer & Director at Mylan, Inc.

Relationship likelihood: Strong

Partner at Mylan Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Commercial Officer at Mylan, Inc.

Relationship likelihood: Strong

President, India Commercial & Emerging Markets at Mylan Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at Nimmagadda Foundation

Relationship likelihood: Strong

Former Chief Executive Officer at Mylan Laboratories, Inc.

Relationship likelihood: Strong

Global General Counsel at Viatris, Inc.

Relationship likelihood: Strong

Paths to Rajiv Malik
Potential Connections via
Relationship Science
You
Rajiv Malik
President at Viatris, Inc.
Education
Master's Degree Pharmacy

Panjab University, Chandigarh is a school.

Career History
President & Director
2007 - Prior

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in approximately 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 18,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service. Through its India-based subsidiary Mylan Laboratories Limited, Mylan has direct access to one of the world’s largest active pharmaceutical ingredient (API) manufacturers. This relationship makes Mylan one of only two global generics companies with a comprehensive, vertically integrated supply chain. Mylan Laboratories Limited also is one of the world’s largest producers of API used to make generic antiretroviral (ARV) therapies for the treatment of HIV/AIDS. Additionally, Mylan operates a fully integrated specialty pharmaceutical business, Mylan Specialty (f/k/a Dey), which produces innovative medicinal therapies, including EpiPen® Auto-Injector

Head, Generics Research & Development
1999 - 2003

Ranbaxy Laboratories Ltd. operated as an integrated international pharmaceutical organization. The company engaged in the marketing, production and distribution of pharmaceutical products. It manufactured and markets molecules and their combinations to therapies, which include anti-infective, cardiovascular, pain management, central nervous system, gastrointestinal, respiratory, dermatology, orthopedics, nutritionals and urology. The company was founded on June 16, 1961 and headquartered in Gurgaon, India.

Head-Global Operations
2007 - 2007

Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories.The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries:a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products.b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market.c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States.The company was incorporated in 1970 and is headquartered in Canonsburg, PA.

Boards & Committees
Member, Board of Directors
2020 - Current

Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines, sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

President & Director
Current

Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV.

Chief Executive Officer, Director & MD
Current

Eurofins Advinus Ltd. engages in the provision of research and development services that supports the discovery and development of compounds for diverse industries. The firm's services include drug and agrochemical discovery and development, biologics testing, and REACH (Registration, Evaluation, and Authorization of Chemicals) support. It serves the pharmaceuticals, biologicals, agrochemicals, nutraceuticals, and cosmetics markets. The company was founded by Kasim A. Mookhtiar in 2005 and is headquartered in Bangalore, India.

Public Holdings
Restricted data only for RelSci Enterprise users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rajiv Malik. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rajiv Malik's profile does not indicate a business or promotional relationship of any kind between RelSci and Rajiv Malik.